FindTrial
Sign In

Dry Eye due to MGD- Conservative treatment v/s Intense Pulsed Light Therapy

Evaluation of Intense Pulsed Light Therapy & Conservative Treatment in Meibomian Gland Disease- A Prospective Observational Comparative Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/064773
Enrollment
120
Registered
2024-03-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H010- Blepharitis

Interventions

Intervention1: NIL: NIL

Sponsors

Tulika Srivastava
Lead Sponsor
Centre for Sight Eye Institute
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 years and above patients diagnosed with MGD patients who are known case of MGD

Exclusion criteria

Exclusion criteria: age below 18 years acute ocular infection or inflammation

Design outcomes

Primary

MeasureTime frame
Improvement of meibomian gland functionTimepoint: 4weeks 12weeks 24weeks—

Secondary

MeasureTime frame
Improvement in symptomsTimepoint: 1 month 3 months 6 months—

Countries

India

Contacts

Public ContactTulika Chauhan

centre for sight eye institute

toolika.chauhan@gmail.com9535133800

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026